Redwood Pharma AB REDW.ST Stock
0.8 SEK
{{ price }}
-2.676401%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
2.56M SEK
LOW - HIGH [24H]
0.73
-
0.9 SEK
VOLUME [24H]
39.92K SEK
{{ volume }}
P/E Ratio
0.061
Earnings per share
12.95 SEK
Redwood Pharma AB Price Chart
Redwood Pharma AB REDW.ST Financial and Trading Overview
| Redwood Pharma AB stock price | 0.8 SEK |
| Previous Close | 0.4 SEK |
| Open | 0.38 SEK |
| Bid | 0.38 SEK x N/A |
| Ask | 0.39 SEK x N/A |
| Day's Range | 0.38 - 0.39 SEK |
| 52 Week Range | 0.14 - 1.87 SEK |
| Volume | 14.32K SEK |
| Avg. Volume | 1.11M SEK |
| Market Cap | 41.23M SEK |
| Beta (5Y Monthly) | 0.47816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 12.95 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
REDW.ST Valuation Measures
| Enterprise Value | 36.29M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | -7737.1626 |
| Price/Book (mrq) | 3.3706899 |
| Enterprise Value/Revenue | -6809.963 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Redwood Pharma AB Stock Price History
| Beta (5Y Monthly) | 0.47816 |
| 52-Week Change | -75.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.87 SEK |
| 52 Week Low | 0.14 SEK |
| 50-Day Moving Average | 0.41 SEK |
| 200-Day Moving Average | 0.47 SEK |
REDW.ST Share Statistics
| Avg. Volume (3 month) | 1.11M SEK |
| Avg. Daily Volume (10-Days) | 571.19K SEK |
| Shares Outstanding | 105.45M |
| Float | 104.24M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 282510.71% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.68% |
| Return on Equity (ttm) | -115.027% |
Income Statement
| Revenue (ttm) | -5329 SEK |
| Revenue Per Share (ttm) | 0.001 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -15051527 SEK |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.73M SEK |
| Total Cash Per Share (mrq) | 0.05 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.248 |
| Book Value Per Share (mrq) | 0.116 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14879964 SEK |
| Levered Free Cash Flow (ttm) | -9237842 SEK |
Profile of Redwood Pharma AB
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Ringvagen 100E |
| ZIP | 118 60 |
| Phone | N/A |
| Website | https://www.redwoodpharma.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB was incorporated in 2012 and is headquartered in Stockholm, Sweden.
Q&A For Redwood Pharma AB Stock
What is a current REDW.ST stock price?
Redwood Pharma AB REDW.ST stock price today per share is 0.8 SEK.
How to purchase Redwood Pharma AB stock?
You can buy REDW.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Redwood Pharma AB?
The stock symbol or ticker of Redwood Pharma AB is REDW.ST.
Which industry does the Redwood Pharma AB company belong to?
The Redwood Pharma AB industry is Biotechnology.
How many shares does Redwood Pharma AB have in circulation?
The max supply of Redwood Pharma AB shares is 3.2M.
What is Redwood Pharma AB Price to Earnings Ratio (PE Ratio)?
Redwood Pharma AB PE Ratio is 0.06177606 now.
What was Redwood Pharma AB earnings per share over the trailing 12 months (TTM)?
Redwood Pharma AB EPS is 12.95 SEK over the trailing 12 months.
Which sector does the Redwood Pharma AB company belong to?
The Redwood Pharma AB sector is Healthcare.
Redwood Pharma AB REDW.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK PI FNSESEKPI | 1878.6 SEK 183.37 USD |
+0.16
|
— — | 1870.08 SEK 182.54 USD | 1889.76 SEK 184.46 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1513.01 EUR 1653.92 USD |
+0.67
|
— — | 1510.95 EUR 1651.67 USD | 1533.41 EUR 1676.23 USD | — - | — — |
| First North Health Care PI FN20PI | 934.74 EUR 1021.8 USD |
-1.95
|
— — | 933.5 EUR 1020.44 USD | 953.35 EUR 1042.15 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 126.34 SEK 12.33 USD |
-0.9
|
— — | 126.23 SEK 12.32 USD | 127.53 SEK 12.45 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.04 DKK 14.82 USD |
-1.33
|
— — | 100.96 DKK 14.8 USD | 102.42 DKK 15.02 USD | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 2001.34 SEK 195.36 USD |
-1.07
|
— — | 1999.37 SEK 195.16 USD | 2020.41 SEK 197.22 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1616.97 EUR 1767.57 USD |
-1.5
|
— — | 1615.38 EUR 1765.82 USD | 1639.39 EUR 1792.08 USD | — - | — — |
| First North Health Care GI FN20GI | 939.04 EUR 1026.5 USD |
-1.95
|
— — | 937.79 EUR 1025.13 USD | 957.74 EUR 1046.94 USD | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 100.98 EUR 110.38 USD |
-1.33
|
— — | 100.89 EUR 110.29 USD | 102.35 EUR 111.88 USD | — - | — — |
- {{ link.label }} {{link}}